Key result
Reduced deceleration capacity, a measure of parasympathetic cardiac modulation, is independently associated with all-cause mortality in individuals with comorbid insomnia and obstructive sleep apnea.
Answers are grounded in this paper and cite their sources.
Assessing cardiac autonomic function via deceleration capacity may improve mortality risk stratification in patients with comorbid insomnia and obstructive sleep apnea beyond traditional respiratory metrics.
Comorbid insomnia and obstructive sleep apnea (COMISA) represent a particularly complex and clinically important phenotype in sleep medicine. Increasing evidence indicates that the coexistence of these two disorders is associated with a higher burden of cardiometabolic disease and mortality compared with either condition alone, with large cohort studies demonstrating a significantly increased risk of all-cause mortality in COMISA populations [1, 2]. Despite this, the pathophysiological mechanisms underlying this excess risk remain incompletely understood, and the current risk stratification approaches continue to rely primarily on respiratory metrics such as the apnea–hypopnea index (AHI), which fail to capture the heterogeneity of clinical outcomes [3]. In this context, the study by Qin et al. provides important insight by extending risk assessment in COMISA beyond respiratory indices to include cardiac autonomic function, assessed through heart rate variability (HRV), using data from the Sleep Heart Health Study [4]. The authors identify deceleration capacity (DC), a measure of parasympathetic cardiac modulation derived from phase-rectified signal averaging, as the most consistent HRV marker associated with all-cause mortality in people with COMISA. Their findings suggest that (1) COMISA is associated with reduced HRV during wakefulness; (2) both insomnia and obstructive sleep apnea (OSA) contribute to altered autonomic regulation prior to sleep onset, characterized by reduced parasympathetic activity, while their coexistence is associated with a persistence of autonomic imbalance during sleep; and (3) reduced DC is independently associated with all-cause mortality in individuals with COMISA.
No takes yet. Share an insight, caveat, or question.
Sabil et al. (2026) conducted an editorial in Comorbid insomnia and obstructive sleep apnea (COMISA). Reduced deceleration capacity (DC) was evaluated on All-cause mortality. Reduced deceleration capacity, a measure of parasympathetic cardiac modulation, is independently associated with all-cause mortality in individuals with comorbid insomnia and obstructive sleep apnea.
Synapse has enriched 10 related papers. Consider them for comparative context: